A detailed history of Allworth Financial LP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 95 shares of ATRC stock, worth $2,677. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Previous 22 331.82%
Holding current value
$2,677
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$19.86 - $29.09 $1,449 - $2,123
73 Added 331.82%
95 $2,000
Q4 2023

Jan 24, 2024

SELL
$32.99 - $43.25 $3,430 - $4,498
-104 Reduced 82.54%
22 $0
Q3 2023

Oct 31, 2023

SELL
$41.12 - $57.73 $1,768 - $2,482
-43 Reduced 25.44%
126 $5,000
Q2 2023

Jul 18, 2023

SELL
$40.44 - $49.6 $4,044 - $4,960
-100 Reduced 37.17%
169 $8,000
Q1 2023

Apr 18, 2023

BUY
$35.87 - $47.22 $9,649 - $12,702
269 New
269 $11,000
Q2 2022

Jul 13, 2022

SELL
$35.1 - $66.01 $5,931 - $11,155
-169 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$57.43 - $71.39 $9,705 - $12,064
169 New
169 $11,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.31B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.